West Pharmaceutical Services WST Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Proprietary Products | $2.62B+5.3% | $2.49B+2.0% | $2.44B+1.9% | $2.4B+2.6% | $2.34B+0.1% | |
| Other segment expense (income) by Business | ||||||
| Proprietary Products | $21.2M+0.5% | $21.1M-21.6% | $26.9M+2.7% | $26.2M+15.9% | $22.6M+2.3% | |
| Total Assets by Business | ||||||
| Proprietary Products | $11.74B+2.7% | $11.43B+3.3% | $11.06B— | —— | —— | |
| Operating Income (Loss) by Business | ||||||
| Proprietary Products | $715.8M+8.9% | $657.2M+4.4% | $629.8M+2.8% | $612.8M+5.3% | $582.1M+0.7% | |
| Selling, general and administrative expenses by Business | ||||||
| Proprietary Products | $260.3M+1.8% | $255.6M+4.1% | $245.5M+3.8% | $236.5M+2.3% | $231.1M-0.2% | |
| Cost of goods and services sold by Business | ||||||
| Proprietary Products | $1.55B+4.6% | $1.48B+0.9% | $1.47B+1.2% | $1.45B+1.3% | $1.43B0.0% | |
| Capital Expenditures by Business | ||||||
| Proprietary Products | $188.9M-7.5% | $204.3M-10.1% | $227.2M0.0% | $227.3M-4.2% | $237.3M-3.7% | |
| R&D by Business | ||||||
| Proprietary Products | $73.8M-0.7% | $74.3M+4.6% | $71M+2.3% | $69.4M+2.4% | $67.8M-1.9% | |
| Depreciation and Amortization by Business | ||||||
| Proprietary Products | $143.9M+2.6% | $140.2M+3.9% | $135M+1.0% | $133.7M+0.5% | $133M+2.1% | |
| Concentration risk, percentage by Product | ||||||
| Standard Packaging | 52%-3.0pp | 55%-2.0pp | 57%-4.0pp | 61%+2.0pp | 59%+11.0pp | |
| Concentration risk, percentage by Geography | ||||||
| Asia Pacific | 26%+1.0pp | 25%— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
